Intra-Cellular Therapies Inc

Ticker ITCI

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in New York City, New York

Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depression…More

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (162)

Intra-Cellular Therapies Inc reports have an aggregate usefulness score of 4.8 based on 162 reviews.

Intra-Cellular Therapies Inc

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Intra-Cellular Therapies Inc has reached its limit for free report views.

Intra-Cellular Therapies Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.